Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression
Clinical Neuropsychopharmacology and Therapeutics · 2020
DOI: 10.5234/cnpt.11.49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2020. Verfasst von Reiji Yoshimura und 3 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yoshimura, R., Okamoto, N., Konishi, Y., & Ikenouchi, A. (2020). Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.11.49
Vancouver
Yoshimura R, Okamoto N, Konishi Y, Ikenouchi A. Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression. Clinical Neuropsychopharmacology and Therapeutics. 2020. doi:10.5234/cnpt.11.49
BibTeX
@article{Yoshimura2020,
author = {Yoshimura, Reiji and Okamoto, Naomichi and Konishi, Yuki and Ikenouchi, Atsuko},
title = {Plasma levels of paroxetine are not associated with the increase of serum levels of brain-derived neurotrophic factor in major depression},
journal = {Clinical Neuropsychopharmacology and Therapeutics},
year = {2020},
doi = {10.5234/cnpt.11.49}
}
EUVIMED